Rebecca Markovich - 17 Jul 2023 Form 4 Insider Report for Talis Biomedical Corp

Role
Interim CFO
Signature
/s/ Gillian Green, Attorney-in-fact for Rebecca Markovich
Issuer symbol
TLIS on OTC
Transactions as of
17 Jul 2023
Net transactions value
$0
Form type
4
Filing time
18 Jul 2023, 17:37:27 UTC
Previous filing
25 Apr 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction TLIS Stock option (right to buy) Award $0 +13,071 $0.000000 13,071 17 Jul 2023 Common Stock 13,071 $7.65 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 25% of the shares underlying this option shall vest on the first annual anniversary of the vesting commencement date of April 21, 2023 and 1/48th of the shares underlying this option shall vest monthly thereafter over 36 months.